
Pasithea Therapeutics Stock Soars After Positive Data From Cancer Drug Trial: Retail’s Elated
The clinical-stage biotechnology company said several patients achieved stable disease and tumor shrinkage while on the treatment. Shares of Pasithea Therapeutics Corp. (KTTA) soared as high as about 150% on Tuesday morning before paring back most of the …